POSITION OF CALCIUM-ANTAGONISTS IN ANTIHYPERTENSIVE THERAPY

被引:43
作者
BUHLER, FR
BOLLI, P
ERNE, P
KIOWSKI, W
MULLER, FB
HULTHEN, UL
JI, BH
机构
[1] UNIV HOSP BASEL, DEPT MED, DIV CARDIOL, CH-4031 BASEL, SWITZERLAND
[2] UNIV HOSP BASEL, DEPT RES, DIV CARDIOL, CH-4031 BASEL, SWITZERLAND
关键词
D O I
10.1097/00005344-198507004-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S21 / S27
页数:7
相关论文
共 56 条
[1]   VERAPAMIL IN THE TREATMENT OF HYPERTENSION [J].
ANAVEKAR, SN ;
CHRISTOPHIDIS, N ;
LOUIS, WJ ;
DOYLE, AE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (02) :287-292
[2]   ANTIHYPERTENSIVE EFFECT OF CARDIOVASCULAR CA2+-ANTAGONIST IN HYPERTENSIVE PATIENTS IN ABSENCE AND PRESENCE OF BETA-ADRENERGIC-BLOCKADE [J].
AOKI, K ;
KONDO, S ;
MOCHIZUKI, A ;
YOSHIDA, T ;
KATO, S ;
KATO, K ;
TAKIKAWA, K .
AMERICAN HEART JOURNAL, 1978, 96 (02) :218-226
[3]  
BENDER F, 1970, ARZNEI-FORSCHUNG, V20, P1310
[4]   SODIUM IONS, CALCIUM-IONS, BLOOD-PRESSURE REGULATION, AND HYPERTENSION - REASSESSMENT AND A HYPOTHESIS [J].
BLAUSTEIN, MP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (05) :C165-C173
[5]  
BOLLI P, 1984, J CARDIOVASC PHARM, V6, pS996
[6]  
BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618
[7]   CLINICAL TRIAL OF HYPOTENSIVE EFFECT OF VERAPAMIL [J].
BRITTINGER, WD ;
SCHWARZBECK, A ;
WITTENMEIER, KW ;
TWITTENHOFF, WD ;
STEGARU, B ;
HUBER, W ;
EWALD, RW ;
HENNING, GEV ;
FABRICIUS, M ;
STRAUCH, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (37) :1871-+
[8]   REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY [J].
BROUWER, RML ;
FOLLATH, F ;
BUHLER, FR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 :S38-S44
[9]  
BUHLER FR, 1982, J CARDIOVASC PHARM, V4, pS350
[10]   PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J].
BUHLER, FR ;
BRUNNER, HR ;
BAER, L ;
VAUGHAN, ED ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) :1209-+